Atlas Trials

Dose-escalation Study of a Contrast Agent for Delineation of Urological Anatomy in Minimally Invasive Surgery

Clinical trial NCT03106038 · COMPLETED

Trial details

NCT number
NCT03106038
Sponsor
Li-Cor, Inc.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Intraoperative Ureter Injury
Start date
2017-04-26
Primary completion
2018-11-19
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.